Skip to Content

Update to Zovirax IV dosing regimen

12/03/2025
Medicines for human use

This update is to inform healthcare professionals about the updates to the dosing regimen for Zovirax IV for Infusion 250 mg, Powder for solution for infusion

Please see the document below for further information.

Product information

Active substance
Aciclovir
Authorisation holder
GlaxoSmithKline (Ireland) Limited
Authorisation number
PA1077/084/003 
Human or veterinary medicine
Human

Documents

Opens in new window Zovirax IV for Infusion 250 mg, Powder for solution for infusion Product Information Updated 12 March 2025 PDF : 115KB | 11/03/2025